Salvage chemotherapy for recurrent spinal cord ependymona (Q33344051)

26 July 2017

title

Salvage chemotherapy for recurrent spinal cord ependymona (English)

1 reference

26 July 2017

1 reference

Marc C Chamberlain

1

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

26 July 2017

1 reference

26 July 2017

volume

95

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

997-1002

1 reference

Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Intracranial ependymoma in children: analysis of prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Primary intraspinal neoplasms in Norway, 1955 to 1986. A population-based survey of 467 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Intramedullary ependymoma of the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Results of microsurgical treatment for intramedullary spinal cord ependymomas: analysis of 36 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Postoperative radiotherapy of primary spinal cord tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Response criteria for phase II studies of supratentorial malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Recurrent brainstem gliomas treated with oral VP-16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Recurrent supratentorial malignant gliomas in children. Long-term salvage therapy with oral etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Chronic oral VP-16 for recurrent medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Recurrent cerebellar gliomas: salvage therapy with oral etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Postoperative radiotherapy in the management of spinal cord ependymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

The role of radiation therapy in the management of ependymomas of the spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

21 January 2018

Chronic oral etoposide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Response of recurrent medulloblastoma to low-dose oral etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Prognostic factors in infants and very young children with intracranial ependymomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma--a report of the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Treatment of high-grade spinal cord astrocytoma of childhood with "8-in-1" chemotherapy and radiotherapy: a pilot study of CCG-945. Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

Ependymomas of the spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

7 January 2021

Adult intramedullary spinal cord ependymomas: the result of surgery in 38 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

7 January 2021

Spinal cord ependymomas: a retrospective analysis of 59 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

7 January 2021

Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10826

7 January 2021

Identifiers

DOI

10.1002/CNCR.10826

1 reference

release_rkffohsojvhzjedzulvnn7giou

26 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rkffohsojvhzjedzulvnn7giou

24 November 2022

mapped directly with Wikidata item

1 reference